Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity

Medical Dosimetry

Volumn 35, Issue 2, 2010, Pages 101-107

  Franks, Kevin N ^a   Purdie, Thomas G ^a,b   Dawson, Laura A ^a,b   Bezjak, Andrea ^a,b   Jaffray, David A ^a,b   Bissonnette, Jean Pierre ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

4DCT; Conformity; Heterogeneity correction; Lung cancer; Organ at risk; Stereotactic body radiotherapy

Indexed keywords

ARTICLE; BREATHING MECHANICS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77952511226     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2009.03.007     Document Type: Article

References (28)

1. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:1427-1431.
2. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101:1623-1631.
3. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51:666-670.
4. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124:1946-1955.
5. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:1010-1015.
6. RTOG 0236 A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer 2006, RTOG, Philadelphia, PA.
7. Ross C.S., Hussey D.H., Pennington E.C., et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int. J. Radiat. Oncol. Biol. Phys. 1990, 18:671-677.
8. Balter J.M., Ten Haken R.K., Lawrence T.S., et al. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36:167-174.
9. Shimizu S., Shirato H., Kagei K.L., et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:1127-1133.
10. van der Geld Y.G., Senan S., van Sornsen de Koste J.R., et al. Evaluating mobility for radiotherapy planning of lung tumors: A comparison of virtual fluoroscopy and 4DCT. Lung Cancer. 2006, 53:31-37.
11. Underberg R.W., Lagerwaard F.J., Cuijpers J.P., et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:1283-1290.
12. Report 62: Prescribing, Recording And Reporting Photon Beam Therapy (Supplement to ICRU Report 50) 1999, International Commission on Radiation Units and Measurements (ICRU), ICRU Publications, Bethesda, MD.
13. Purdie T.G., Bissonnette J.P., Franks K., et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:243-252.
14. Purdie T.G., Moseley D.J., Bissonnette J.P., et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy. Acta Oncol. 2006, 45:915-922.
15. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 1999, 45:323-329.
16. Feuvret L., Noel G., Mazeron J.J., et al. Conformity index: A review. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:333-342.
17. van't Riet A., Mak A.C., Moerland M.A., et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate. In. J. Radiat. Oncol. Biol. Phys. 1997, 37:731-736.
18. Butson M.J., Elferink R., Cheung T., et al. Verification of lung dose in an anthropomorphic phantom calculated by the collapsed cone convolution method. Phys. Med. Biol. 2000, 45:N143-N149.
19. Bedford J.L., Childs P.J., Nordmark Hansen V., et al. Commissioning and quality assurance of the Pinnacle3 radiotherapy treatment planning system for external beam photons. Br. J. Radiol. 2003, 76:163-176.
20. Ding G.X., Duggan D.M., Lu B., et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med. Phys. 2007, 34:2985-2994.
21. Traberg Hansen A., Petersen J.B., Hoyer M., et al. Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning. Radiother. Oncol. 2005, 77:96-98.
22. Alvarez P.E., Molineu A., Hernandez N., et al. Analysis of multiple irradiations of an anthropomorphic thorax phantom containing lung heterogeneities. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:S685.
23. RTOG 0618 A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer 2007, RTOG, Philadelphia, PA.
24. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 2006, 24:4833-4839.
25. Guckenberger M., Wilbert J., Krieger T., et al. Four-dimensional treatment planning for stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:276-285.
26. Rosu M., Balter J.M., Chetty I.J., et al. How extensive of a 4D dataset is needed to estimate cumulative dose distribution plan evaluation metrics in conformal lung therapy?. Med. Phys. 2007, 34:233-245.
27. Shaw E., Kline R., Gillin M., et al. Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines. Int. J. Radiat. Oncol. Biol. Phys. 1993, 27:1231-1239.
28. Lomax N.J., Scheib S.G. Quantifying the degree of conformity in radiosurgery treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55:1409-1419.